CIAM
VNDA icon

Caitong International Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Caitong International Asset Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37.8K Sell
5,473
-23,685
-81% -$183K 0.01% 864
2025
Q4 		$257K Buy
29,158
+28,824
+8,630% +$159K 0.06% 152
2025
Q3 		$1.67K Sell
334
-330
-50% -$1.53K ﹤0.01% 1404
2025
Q2 		$3.13K Buy
+664
New +$2.9K ﹤0.01% 1215

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Caitong International Asset Management's VNDA Position: Q1 2026 in Review

Caitong International Asset Management reduced its Vanda Pharmaceuticals (VNDA) stake by 81% in Q1 2026, selling an estimated $183K and leaving 5,473 shares worth $37.8K. The position accounts for 0.01% of the portfolio, ranked #864.

Caitong International Asset Management first reported a position in VNDA in Q2 2025 and has held it in 4 quarters since. The position peaked at $257K in Q4 2025. 170 funds tracked by Wall St. Rank hold VNDA as of Q1 2026.

  • Caitong International Asset Management held 5,473 shares of Vanda Pharmaceuticals worth $37.8K as of Q1 2026.
  • Caitong International Asset Management sold 23,685 Vanda Pharmaceuticals shares in Q1 2026, an estimated $183K.
  • Vanda Pharmaceuticals made up 0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #864 holding.
  • Caitong International Asset Management first reported a position in Vanda Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • Caitong International Asset Management's Vanda Pharmaceuticals position peaked at $257K in Q4 2025.
  • 170 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.